The company with capital from the Canary Islands has been acknowledged as an innovative SME by the Ministry of Economy, Industry and Competitiveness. On 4 December Adventia will form part of the 'research, science, technology and innovation' exhibition organized by the Industrial and Technological Development Centre (CDTI in Spanish), within the framework of the commemorative events for the 40th Anniversary of the Constitution. 

Of the 21 Spanish companies selected for their work in Research and Development, Adventia is the only one from the Canary Islands to take part in the exhibition to be held at the MUNCYT, the National Science and Technology Museum in A Coruña up to 20 January.  

Adventia is a pharmaceutical laboratory specializing in the development, manufacturing and marketing of food for specialized medical use. More specifically, its activity is based in the field of Advanced Medical Nutrition for the treatment of cancer patients, where the company already boasts a consolidated track record in the Spanish market and has now set out on its international projection.

Adventia's participation in the national exhibition will be focused on the Alisenoc project, a research project into a diet with new nutritional and sensorially appropriate complements for cancer patients, at present non-existent on the international market. The purpose is to improve the nutritional status and quality of life of patients with cancer.